📅World Orphan Drug Congress USA 2025: April 22-24, 2025 | Boston, MA
Ergomed delivers customized solutions for biotech and pharmaceutical companies, focusing on innovation, efficiency, and patient-centricity. From launching clinical trials to managing post-approval safety, our expert team provides the guidance and support needed to achieve your development goals.
April 23 | 12:05
“Clinical Development & Regulatory: Unique Execution Strategies for Complex Trials in Rare Diseases”
April 23 | 12:05
“Clinical Development & Regulatory: Unique Execution Strategies for Complex Trials in Rare Diseases”
April 23 | 11:25
“Rare Advocacy: Facilitating a Non-US Sponsor’s Engagement with a Rare Disease Patient Advocacy Organization (case study)”
April 23 | 12:05
“Clinical Development & Regulatory: Unique Execution Strategies for Complex Trials in Rare Diseases”
Our team will be at Booth #630 to dive deep into our innovative solutions tailored to address the unique challenges of rare disease research as well as how we prioritize patient needs and empower their voices in the drug development journey.
Schedule a meeting to learn how Ergomed can help transform your clinical development journey.
"*" indicates required fields